strain I (Bethesda Research Laboratories, Bethesda, MD). Because we found that serumcontaining media often suppressed the subsequent response of in vitro-activated B cells to IL-2, TNF, and BCGF (our unpublished observation), on the second day of culture the cells were harvested, washed twice with RPMI 1640, and recultured in Ventrex HL-1 serum-free media (Ventrex Laboratories, Inc., Portland, ME) at a concentration of 5 x 105 cells/ml in 96-well Costar plates in the presence or absence of various cytokines. The culture was continued for the indicated time periods, and DNA synthesis was measured during the last 18 h of the culture period by the incorporation of ['H]thymidine using standard liquid scintillation counting techniques. The anti-ju costimulation assay was performed as previously described (1) . IgG and IgM levels in culture supernatants were measured by an isotype-specific ELISA .
Receptor Studies. Purified recombinant TNF-a (10 jug) was radiolabelled using iodobeads (Pierce Chemical Co., Rockford, IL) and separated from free iodide by filtration over a Sephadex G-25 column . The radiolabelled TNF had a s?ecific activity of 5.7 mCi/mg and was biologically active when assayed on L929 cells . 25 ng/ml of TNF-a to these cultures resulted in a fivefold increase in thymidine incorporation compared to B cells cultured with media alone. Half-maximal stimulation occurred at a concentration of 5 ng/ml (285 pM) of TNF-a . Using an anti-A costimulation assay, we next examined whether TNF-a could enhance anti-p-triggered B cell proliferation . TNF-a could costimulate with antik in this assay, but not as efficiently as a BCGF preparation (Fig. 1 B) .
TNF-a Enhances the Effects of IL-1, IL-2, and IFN-y on SAC-activated B Cell Proliferation . To test whether TNF-a modulated the effects of factors known to enhance B cell function (1, (10) (11) (12) , optimal concentrations of BCGF, IL-1, IL-2, and IFN-y were added to 2-d SAC-activated B cells in conjunction with increasing concentrations of TNF-a (Fig. 2) . DNA synthesis was measured 3 and 5 d later. TNF-a augmented the B cell proliferation compared to a media control at both days 5 and 7. The addition of TNF-a to either IL-1 or IFN-y resulted in a greater increase in DNA synthesis than did either factor alone at both day 5 and day 7. Additionally, TNF-a increased IL-2-induced B cell proliferation at both days 5 and 7 by 40%, but it did not augment BCGF induced proliferation at either time . Subsequently, the BCGF preparation was found to contain a moderate concentration of TNF (data not shown) .
TNF-a Itself Does Not Induce Ig Secretion by SAC-activated Human B Cells, But It Can Augment IL-2-induced IgM Secretion of These Cells. Because of the original report that serum from BCG-infected and LPS-challenged mice, in conjunction TNF-a augments IL-2 induced B cell differentiation . B cells were activated with SAC for 2 d, washed, and recultured in serum-free medium in the presence or absence of 100 U/ml IL-2 with varying concentrations of TNF-a. Supernatant IgM levels were measured 7 d later using an ELISA (mean ± SEM of two experiments) . with antigen, would induce murine B cell Ig secretion (3, 4), we were interested in examining the effects of TNF-a on human B cell differentiation to Ig secretion . Using B cells preactivated in vitro with SAC, we added various concentrations of TNF-a to cultures and measured supernatant Ig concentration 5 d later. TNF-a by itself did not promote preactivated B cells to secrete Ig but it did enhance (twofold) the IgM production induced by IL-2 (Fig. 3) . Of note, the effects of TNF-a on IgM production were more pronounced than its effects on IgG secretion (data not shown) .
Expression of TNF-a Receptors on Human B Cells. To further characterize the role of TNF-a in B cell function, receptor binding studies with 125 1-TNF-a were performed. Unstimulated B cells had low levels of receptors not quantifiable using the LIGAND program; however, B cells that were cultured with SAC for 2 d had an average of 6,000 receptors per cell, with a Kd of 2 .0 X 10 -I°M (200 pM) (Fig. 4) . A linear Scatchard was found, which suggests a single affinity class of receptors. The binding of TNF-a to SAC-activated B cells was not secondary to the presence of SAC in the culture, since the addition of SAC to the unactivated B cells before the binding assay did not alter the results (data not shown) . Discussion TNF-a has been generally defined by its cytotoxic or cytostatic activity against certain transformed cell lines. However, recently, Sugarman et al . (13) found that TNF-a actually enhanced the growth of certain normal cell lines . Additionally, Vilcek et al. (9) have noted that the growth of human FS-4 diploid fibroblasts was stimulated by TNF-a. In the present study we demonstrate that TNF-a can also significantly enhance the proliferation of activated B cells. These bifunctional effects of TNF-a on cell growth, although unusual, are not unique, as several other growth factors that can provide positive or negative growth signals, such as transforming growth factor /3, have been identified (15) . The growth-promoting effects of TNF-a for normal human B cells gives further credence to the hypothesis (14) that TNF-a is a growth factor for certain types of normal cells and that its antiproliferative effects on transformed cells is the result of an aberrant response to growth stimulation in cells that lack normal growth regulatory mechanisms .
Binding studies with radiolabelled TNF-a have been previously performed using cell lines that are sensitive targets for the cytotoxic effects of TNF. 
Summary
In this study we demonstrate that the monocyte/macrophage product, tumor necrosis factor a (TNF-a), has significant in vitro effects of B cell function . It costimulated with anti-A in the induction of B cell DNA synthesis, and it prolonged the DNA synthesis initiated in B cell cultures stimulated with the human B cell mitogen, Staphylococcus aureus Cowan strain I (SAC). The addition of either IL-1 or IFN-y to TNF-a resulted in a substantial further increase in DNA synthesis. The addition of TNF-a to IL-2, a known inducer of SAG activated B cell Ig secretion, resulted in a twofold enhancement in the amount of IL-2 stimulated B cell Ig secretion. Receptor binding studies with 125 1-TNF-a demonstrate a marked increase in TNF-a binding sites after B cell activation (6,000 sites per cell, with an apparent Kd of 2.0 X 10-'°M). Thus, TNF-a may be an important factor in human B cell function and is likely to interact with other T cell and monocyte derived cytokines in the regulation of human B cell proliferation and Ig production.
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